Accendra Health Inc (ACH) Stock Forecast
ACH analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 2.60 / 5 from 5 analysts
- Price target
- $1.26 average of analyst targets
- Upside to target
- +426.0% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $-0.04
- 52-week range
- $0.24 – $5.51
ACH analyst ratings
5 analystsNumber of analysts at each rating.
ACH price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ACH earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.09 | −$0.42 | $0.03 | $0.25 | −136.6% | 5 |
| Current fiscal year (2026) | −$0.06 | −$0.28 | $0.06 | $1.01 | −106.3% | 5 |
| Next fiscal year (2027) | $0.09 | −$0.18 | $0.36 | −$0.06 | +234.7% | 5 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ACH revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $617.4M | $612.3M | $623.0M | −11.5% | 5 |
| Current fiscal year (2026) | $2.49B | $2.48B | $2.50B | −9.8% | 5 |
| Next fiscal year (2027) | $2.56B | $2.51B | $2.62B | +3.0% | 5 |
ACH EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ACH revenue: reported and forecast
ACH EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.21 | −$0.00 | −$0.07 | −$0.09 | −$0.09 | −144.2% | 0 up · 5 down |
| Current fiscal year (2026) | $0.42 | $0.01 | −$0.04 | −$0.06 | −$0.06 | −115.1% | 0 up · 5 down |
| Next fiscal year (2027) | $0.69 | $0.40 | $0.15 | $0.09 | $0.09 | −87.6% | 0 up · 5 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ACH earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ACH beat in 7 of 10.
What analysts expect from ACH
5 analysts cover Accendra Health; their consensus rating is hold (2.60 on a 1–5 scale, where 5 is a strong buy). The average price target is $1.26, 426.0% above the latest close of $0.24. Analysts expect earnings of −$0.06 per share for 2026, −106.3% from a year earlier. For 2027 the average estimate is $0.09 per share on revenue of $2.6 billion. Accendra Health beat the EPS estimate in 7 of the last 10 quarters.
Related: ACH income statement, ACH key metrics, ACH chart. See the ACH stock overview for the latest quote and news.
ACH forecast FAQ
What is Accendra Health's price target?
The average analyst price target for Accendra Health is $1.26, 426.0% above the latest close of $0.24.
Is Accendra Health a buy, hold or sell?
Of 5 analysts covering Accendra Health, 0 rate it a strong buy, 0 a buy, 3 a hold, 2 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Accendra Health's EPS forecast?
Analysts forecast −$0.06 per share for 2026 (range −$0.28 to $0.06); for 2027 the estimate is $0.09.
What is Accendra Health's revenue forecast?
The average revenue estimate for 2026 is $2.5 billion, growth of −9.8%; for 2027 it is $2.6 billion.
When does Accendra Health report earnings?
Accendra Health is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 before the market opens; the EPS estimate is $-0.04.
Does Accendra Health usually beat earnings estimates?
Accendra Health reported EPS at or above the analyst estimate in 7 of the last 10 quarters.